304
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Provider beliefs on the Barriers and Facilitators to Prescription Monitoring Programs and Mandated Use

, , , , & ORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Steven J Scrivani, David A Keith, Ronald J Kulich, Alexandre F DaSilva, R Bruce Donoff, Shruti Handa, Nicole Holland, Mark A Lerman, Jenna L McCauley, Lori Reisner, Cory M Resnick, Christian S Stohler, Alexis Vasciannie, Matthew Fortino & Michael E Schatman. (2021) Pain Management for Dental Medicine in 2021: Opioids, Coronavirus and Beyond. Journal of Pain Research 14, pages 1371-1387.
Read now

Articles from other publishers (6)

Dimi Hoppe, Chaojie (George) Liu & Hanan Khalil. (2023) Health‐care practitioner use of prescription drug monitoring programs in clinical practice in Australia: A qualitative study. Drug and Alcohol Review 42:7, pages 1647-1657.
Crossref
Louisa Picco, Tina Lam, Ting Xia & Suzanne Nielsen. (2022) Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists. International Journal of Clinical Pharmacy 45:2, pages 421-429.
Crossref
Dimi Hoppe, Chaojie (George) Liu & Hanan Khalil. (2023) Healthcare practitioner use of real-time prescription monitoring tools: an online survey. Australian Health Review 47:2, pages 208-216.
Crossref
Adam SacarnyTatyana AvilovaDavid PowellIan WilliamsonWeston MerrickMireille Jacobson. (2023) A Randomized Trial Of Letters To Encourage Prescription Monitoring Program Use And Safe Opioid Prescribing. Health Affairs 42:1, pages 140-149.
Crossref
Matthew Witry, Barbara St Marie & Jeffrey Reist. (2022) Provider perspectives and experiences following the integration of the prescription drug monitoring program into the electronic health record. Health Informatics Journal 28:3, pages 146045822211134.
Crossref
Dimi Hoppe, Leila Karimi & Hanan Khalil. (2022) Mapping the research addressing prescription drug monitoring programs: A scoping review. Drug and Alcohol Review 41:4, pages 803-817.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.